Emma Hall Selected Research

Emma Hall Research Topics

Disease

31	Prostatic Neoplasms (Prostate Cancer) 01/2022 - 01/2012
25	Neoplasms (Cancer) 01/2022 - 02/2006
16	Urinary Bladder Neoplasms (Bladder Cancer) 01/2022 - 10/2011
12	Breast Neoplasms (Breast Cancer) 01/2021 - 03/2004
6	Head and Neck Neoplasms (Head and Neck Cancer) 10/2021 - 02/2011
5	Fatigue 11/2020 - 02/2011
4	Neoplasm Metastasis (Metastasis) 01/2022 - 10/2007
4	Deglutition Disorders (Dysphagia) 10/2021 - 11/2013
4	Disease Progression 12/2020 - 01/2017
4	Non-Muscle Invasive Bladder Neoplasms 01/2020 - 12/2014
3	Xerostomia 11/2013 - 02/2011
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2022 - 02/2011
2	Hypoxia (Hypoxemia) 01/2021 - 02/2017
2	Pharyngeal Neoplasms 01/2021 - 10/2016
2	Carcinoma (Carcinomatosis) 07/2020 - 01/2020
2	Transitional Cell Carcinoma 01/2019 - 10/2012
2	Residual Neoplasm 11/2017 - 03/2005
2	Circulating Neoplastic Cells 04/2017 - 10/2015
2	Pain (Aches) 01/2014 - 04/2006
2	Radiation Fibrosis Syndrome (Radiation Fibrosis) 06/2005 - 11/2004
2	Fibrosis (Cirrhosis) 11/2004 - 03/2004
1	Glioblastoma (Glioblastoma Multiforme) 01/2022
1	Spinal Cord Compression 01/2022
1	Penile Neoplasms (Penile Cancer) 01/2022
1	Triple Negative Breast Neoplasms 01/2021
1	Hypopharyngeal Neoplasms 01/2021
1	Oropharyngeal Neoplasms 01/2021
1	Exanthema (Rash) 11/2020
1	Multiple Myeloma 11/2020
1	Retinal Detachment (Retinal Detachments) 11/2020
1	Erectile Dysfunction 03/2020
1	Hemorrhage 01/2020
1	Fallopian Tube Neoplasms 11/2019
1	Adenocarcinoma 11/2019
1	Carcinoma in Situ 01/2019
1	Sensorineural Hearing Loss 11/2018
1	Parotid Neoplasms 11/2018
1	Necrosis 02/2017
1	Genetic Predisposition to Disease (Genetic Predisposition) 10/2016
1	Anemia 10/2015
1	Acute Pain 01/2014
1	Postoperative Pain 01/2014

Drug/Important Bio-Agent (IBA)

7	Biomarkers (Surrogate Marker)IBA 11/2021 - 02/2007
6	Prostate-Specific Antigen (Semenogelase)IBA 12/2020 - 10/2015
5	Mitomycin (Mitomycin-C)FDA LinkGeneric 01/2022 - 04/2012
5	Fluorouracil (Carac)FDA LinkGeneric 01/2022 - 05/2009
5	olaparibIBA 10/2020 - 10/2015
4	Poly(ADP-ribose) Polymerase InhibitorsIBA 11/2021 - 10/2015
3	Pharmaceutical PreparationsIBA 11/2020 - 04/2006
3	taxaneIBA 01/2020 - 05/2009
3	PlatinumIBA 01/2020 - 01/2017
3	Celecoxib (Celebrex)FDA Link 01/2019 - 10/2011
3	Tamoxifen FDA LinkGeneric 02/2007 - 03/2004
3	exemestane (Aromasin)FDA Link 02/2007 - 03/2004
2	Carisoprodol (Soma)FDA LinkGeneric 01/2020 - 02/2011
2	Cell-Free Nucleic AcidsIBA 01/2018 - 01/2017
2	Docetaxel (Taxotere)FDA Link 05/2009 - 10/2007
2	Estrogen ReceptorsIBA 10/2007 - 03/2004
2	Pentoxifylline (Trental)FDA LinkGeneric 06/2005 - 11/2004
2	alpha-Tocopherol FDA Link 06/2005 - 11/2004
1	vinflunineIBA 01/2022
1	Dihydrotachysterol (AT 10)IBA 12/2021
1	Radioisotopes (Radionuclides)IBA 10/2021
1	Radium-223IBA 10/2021
1	IPCMIBA 01/2021
1	palbociclibIBA 01/2021
1	2- (3- (2- (1- isopropyl- 3- methyl- 1H- 1,2- 4- triazol- 5- yl)- 5,6- dihydrobenzo(f)imidazo(1,2- d)(1,4)oxazepin- 9- yl)- 1H- pyrazol- 1- yl)- 2- methylpropanamideIBA 01/2021
1	Fulvestrant (Faslodex)FDA Link 01/2021
1	GoldIBA 01/2021
1	Cyclin-Dependent Kinase 4IBA 01/2021
1	RO5126766IBA 11/2020
1	CreatinineIBA 11/2020
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 11/2020
1	capivasertibIBA 10/2020
1	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 01/2019
1	DNA (Deoxyribonucleic Acid)IBA 01/2018
1	Genetic Markers (Genetic Marker)IBA 08/2016
1	TabletsIBA 10/2015
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 10/2015
1	Adenosine Diphosphate (ADP)IBA 10/2015
1	Adenosine Diphosphate Ribose (ADP-Ribose)IBA 10/2015
1	Acetaminophen (Paracetamol)FDA LinkGeneric 01/2014
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2014
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 05/2013
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 05/2013

Therapy/Procedure

56	Radiotherapy 01/2022 - 03/2004
18	Therapeutics 12/2021 - 03/2004
17	Drug Therapy (Chemotherapy) 01/2022 - 10/2007
16	Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated) 12/2021 - 01/2012
8	Castration 01/2022 - 10/2015
6	Cystectomy 01/2022 - 04/2012
3	Neoadjuvant Therapy 01/2021 - 11/2017
3	Adjuvant Chemotherapy 01/2020 - 10/2007
2	Chemoradiotherapy 01/2022 - 01/2022
1	Aftercare (After-Treatment) 12/2021
1	Image-Guided Radiotherapy 01/2020
1	Transurethral Resection of Bladder 01/2019
1	Particle Accelerators 01/2017
1	Oral Surgery (Maxillofacial Surgery) 01/2014
1	Postoperative Care 10/2012